T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL) research hub

A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma

This study is looking into a new medicine, KK2223, for people in the UK who have a type of blood cancer called T-cell non-Hodgkin lymphoma. It's the very first time this medicine is being tested in humans to see if it's safe and how it works.